BamSEC and AlphaSense Join Forces
Learn More

Corus Pharma Inc

Material Contracts Filter

EX-10.28
from S-1/A 3 pages A. Bruce Montgomery, M.D. Chief Executive Officer
12/34/56
EX-10.27
from S-1/A 8 pages Engagement Agreement
12/34/56
EX-10.26
from S-1/A 5 pages Settlement Agreement and General Release
12/34/56
EX-10.25
from S-1/A 3 pages [Letterhead of Cystic Fibrosis Foundation Therapeutics, Inc.] September 25, 2003
12/34/56
EX-10.23
from S-1/A 30 pages Mayo Foundation for Medical Education and Research Technology License Contract Article 1.00 – Preliminary Provisions
12/34/56
EX-10.21
from S-1/A 13 pages Services Agreement
12/34/56
EX-10.20
from S-1/A 10 pages Master Services Agreement
12/34/56
EX-10.19
from S-1/A 9 pages Master Services Agreement
12/34/56
EX-10.18
from S-1/A 15 pages Pharmaceutical Supply Agreement
12/34/56
EX-10.17
from S-1/A 75 pages Development Agreement Between Salus Pharma, Inc. and Pari Gmbh
12/34/56
EX-10.16
from S-1/A 94 pages Development Agreement Between Abaris Pharma, Inc. and Pari Gmbh
12/34/56
EX-10.24
from S-1 12 pages Change in Control Severance Agreement
12/34/56
EX-10.22
from S-1 7 pages Employee Confidentiality, Inventions, and Non-Competition Agreement
12/34/56
EX-10.15
from S-1 1 page June 22, 2004 via U.S. Postal Service A. Bruce Montgomery, M.D. Corus Pharma, Inc. 2025 First Avenue, Suite 800 Seattle, Wa 98121 Re: Sublease at 3005 First Avenue
12/34/56
EX-10.14
from S-1 5 pages Second Amendment to Sublease
12/34/56
EX-10.13
from S-1 6 pages Consent to Second Amendment to Sublease
12/34/56
EX-10.12
from S-1 5 pages Amendment to Sublease
12/34/56
EX-10.11
from S-1 6 pages Consent to Amendment to Sublease
12/34/56
EX-10.10
from S-1 11 pages Recitals Agreement
12/34/56
EX-10.9
from S-1 6 pages Consent to Sublease
12/34/56